Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Clinical trial NCT06967961 · RECRUITING

Trial details

NCT number: NCT06967961
Sponsor: Institut Claudius Regaud
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Urothelial Carcinoma Renal Cancer Prostate Adenocarcinoma Adenocarcinoma of Endometrium Cutaneous Melanoma Soft Tissue Sarcoma (STS)Nonseminomatous Germ Cell Tumor Seminomatous Germ Cell Tumor Upper Aerodigestive Tract Carcinoma Cervical Carcinoma

Start date: 2025-07-23
Primary completion: 2029-07-23
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.